Objectives. To study the clinical and electroencephalographic characteristics of early infantile epileptic encephalopathy (EIEE) type 14, due to mutations in the KCNT1 gene. Materials and methods. Over the period 2017–2019, three unrelated girls (M.V. aged three years three months, T.V. aged nine months, and M.U. aged five months) with the clinical picture of infantile epilepsy with migrating focal seizures (IEMFS) were investigated and mutations in the KCNT1 gene were identified. New-generation DNA sequencing (Inherited Epilepsy panel) was run on an Illumina NextSeq 500 platform (USA). Video EEG monitoring was with an Encephalan Video system based on an Encephalan-RM RM-EEG-19/26 instrument (Medikom MTD, Russia). Results and conclusions. M.V. showed a previously undescribed mutation in exon 12 of the KCNT1 gene (chr9:138656907C>T) with amino acid substitution Arg356Trp. T.V. had a known mutation in chromosome 9, 138651532G>A with amino acid substitution of glycine by serine as position 288, i.e., Gly288Ser (OMIM: 608167.0010). M.U. showed a previously undescribed heterozygous mutation in exon 15 of the KCTN1 gene (chr9:138660712A>G), leading to an amino acid substitution in position 480 (Asp480Gly). In M.V., the onset of EIEE was at age four months with hypomotor dialeptic and tonic versive seizures. Epilepsy in T.V. started at age 4.5 months with hypomotor seizures with ophthalmoclonia and facial hyperemia. In M.V., neonatal convulsions were seen with bilateral tonic-clinic seizures and cyanosis, and subsequent development of status epilepticus with alternating hemiconvulsions. All girls went on to develop seizures of multiregional genesis to the level of migrating status epilepticus with the typical electroclinical picture of IEMFS. Thus, these findings lead to the conclusion that the KCNT1 gene may be the main gene determining the development of EIEE.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
J. R. Engel and the International League Against Epilepsy (ILAE), “A Proposed diagnostic schema for people with epileptic seizures and with epilepsy,” Epilepsia, 42, No. 6, 796–803 (2001).
A. A. Sharkov, I. V. Sharkova, E. D. Belousova, and E. L. Dadali, “The genetics and differential treatment of early infantile epileptic encephalopathies,” Zh. Nevrol. Psikhiat., 116, No. 9–2, 67–73 (2016), https://doi.org/10.17116/jnevro20161169267-73.
Moscow (Online Mendelian Inheritance in Man), an Online Catalog of Human Genes and Genetic Disorders, upd. Feb. 1, 2019, https://omim.org/phenotypicSeries/PS308350?sort=phenotype.
G. Barcia, M. R. Fleming, A. Deligniere, et al., “De novo gain-offunction KCNT1 channel mutations cause malignant migrating partial seizures of infancy,” Nat. Genet., 44, 1255–1259 (2012), https://doi.org/10.1038/ng.2441.
G. Coppola, P. Plouin, C. Chiron, et al., “Migrating partial seizures in infancy: a malignant disorder with developmental arrest,” Epilepsia, 36, No. 10, 1017–1024 (1995).
O. Dulac, “Malignant migrating partial seizures in infancy,” in: Epileptic Syndromes in Infancy, Childhood and Adolescence, J. Roger et al. (eds.), John Libbey (2005), 4th ed.
I. E. Scheffer, S. Berkovich, G. Capovilla, et al., “ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology,” Epilepsia, 58, No. 4, 512–521 (2017), https://doi.org/10.1111/epi.13709.
A. A. Kholin, “Malignant migrating partial seizures in infancy or Coppola-Dulac syndrome,” in: Proc. 29th Int. Epilepsy Congress, Rome (2011).
A. A. Kholin, Status Epilepticus in Infancy and Early Childhood: Auth. Abstr. of Doct. Thesis in Med. Sci., Moscow (2000).
A. Poduri, E. L. Heinzen, V. Chitsazzadeh, et al., “SLC25A22 is a novel gene for migrating partial seizures in infancy,” Ann. Neurol., 74, No. 6, 873–882 (2013), https://doi.org/10.1002/ana.23998.
E. R. Freilich, J. M. Jones, W. D. Gaillard, et al., “Novel SCN1A mutation in a proband with malignant migrating partial seizures of infancy,” Arch. Neurol., 68, No. 5, 665–671 (2011), https://doi.org/10.1001/archneurol.2011.98.
D. Carranza Rojo, L. Hamiwka, J. M. McMahon, et al., “De novo SCN1A mutations in migrating partial seizures of infancy,” Neurology, 77, No. 4, 380–383 (2011), https://doi.org/10.1212/WNL.0b013e318 227046d.
A. Poduri, S. S. Chopra, E. G. Neilan, et al., “Homozygous PLCB1 deletion associated with malignant migrating partial seizures in infancy,” Epilepsia, 53, No. 8, 146–150 (2012), https://doi.org/10.1111/j.1528-1167.2012.03538.x.
C. Ohba, M. Kato, S. Takahashi, et al., “Early onset epileptic encephalopathy caused by de novo SCN8A mutations,” Epilepsia, 55, No. 7, 994–1000 (2014), https://doi.org/10.1111/epi.12668.
A. Ishii, M. Shioda, A. Okumura, et al., “A recurrent KCNT1 mutation in two sporadic cases with malignant migrating partial seizures in infancy,” Gene, 531, No. 2, 467–471 (2013), https://doi.org/10.1016/j.gene.2013.08.096.
A. Vanderver, C. Simons, J. L. Schmidt, et al., “Identification of a novel de novo p.Phe932Ile KCNT1 mutation in a patient with leukoencephalopathy and severe epilepsy,” Pediatr. Neurol., 50, No. 1, 112–114 (2014), https://doi.org/10.1016/j.pediatrneurol.2013.06.024.
M. Milh, A. Falace, N. Villeneuve, et al., “Novel compound heterozygous mutations in TBC1D24 cause familial malignant migrating partial seizures of infancy,” Hum. Mutat., 34, No. 6, 869–872 (2013) https://doi.org/10.1002/humu.22318.
X. Zhang, J. Ling, G. Barcia, et al., “Mutations in QARS, encoding glutaminyl-tRNA synthetase, cause progressive microcephaly, cerebral- cerebellar atrophy, and intractable seizures,” Am. J. Hum. Genet., 94, No. 4, 547–558 (2014), https://doi.org/10.1016/j.ajhg.2014.03.003.
P. Madaan, P. Jauhari, A. Gupta, et al., “A quinidine non responsive novel KCNT1 mutation in an Indian infant with epilepsy of infancy with migrating focal seizures,” Brain Dev., 40, No. 3, 229–232 (2018), https://doi.org/10.1016/j.braindev.2017.09.008.
E. Veneselli, M. V. Perrone, M. Di Rocco, et al., “Malignant migrating partial seizures in infancy,” Epilepsy Res., 46, No. 1, 27–32 (2001).
G. Coppola, “Malignant migrating partial seizures in infancy: an epilepsy syndrome of unknown etiology,” Epilepsia, 50, No. 5, 49–51 (2009).
A. A. Kholin, E. S. Il’ina, L. M. Kolpakchi, et al., “Malignant migrating partial seizures in infancy. Clinical observation of 6 cases,” Russ. Zh. Detsk. Nevrol., 2, No. 2, 25–38 (2007).
A. A. Kholin, “Malignant migrating partial seizures in infancy or Coppola–Dulac syndrome,” Zh. Nevrol. Psikhiat., 113, No. 3, 21–27 (2013).
J. Perez, C. Chiron, C. Musial, et al., “Stiripentol: efficacy and tolerability in epileptic children,” Epilepsia, 40, No. 11, 1618–1622 (1999).
K. Okuda, A. Yasuhara, A. Kamei, et al., “Successful control with bromide of two patients with malignant migrating partial seizures in infancy,” Brain Dev., 22, No. 1, 56–59 (2000).
E. Abdelnour, W. Gallentine, M. McDonald, et al., “Does age affect response to quinidine in patients with KCNT1 mutations? Report of three new cases and review of the literature,” Seizure, 55, 1–3 (2018), https://doi.org/10.1016/j.seizure.2017.11.017.
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Zhurnal Nevrologii i Psikhiatrii imeni S. S. Korsakova, Vol. 119, No. 7, Iss. 2, Pediatric Neurology and Psychiatry, pp. 74–82, July, 2019.
Rights and permissions
About this article
Cite this article
Kholin, A.A., Zavadenko, N.N., Fedonyuk, I.D. et al. Early Infantile Epileptic Encephalopathy Type 14: Three Cases of Infantile Epilepsy with Migrating Focal Seizures Due to Mutations in the KCNT1 Gene. Neurosci Behav Physi 50, 534–540 (2020). https://doi.org/10.1007/s11055-020-00933-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11055-020-00933-y